IDXX vs ORGO · P/E 40, rev $2.36B vs rev $81.0M
IDEXX Laboratories Inc (IDXX) versus Organogenesis Holdings Inc (ORGO) — a side-by-side from cached financials, not a winner call.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Organogenesis Holdings Inc (ORGO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Latest reported ORGO revenue for 2026-06-30 was $81.0M. Net income was -$149.4M. ORGO currently screens at market cap $301.1M.
IDXX currently screens at market cap $43.08B and trailing P/E 40.2. ORGO currently screens at market cap $301.1M.
Not investment advice. Open the IDXX and ORGO stock pages for the full models.
Not investment advice.